Matches in SemOpenAlex for { <https://semopenalex.org/work/W3012149196> ?p ?o ?g. }
- W3012149196 endingPage "1289" @default.
- W3012149196 startingPage "1278" @default.
- W3012149196 abstract "Nucleotides mediate intercellular communication by activating purinergic receptors and take part in various physiological and pathological processes. Abnormal purinergic signaling plays important roles in malignant progression. P2X7, which belongs to the P2X family of purinergic receptors, is abnormally expressed in various types of malignancies including leukemia. However, its role and molecular mechanism in leukemia have not been elucidated. Here, we analyzed the correlation between P2X7 expression and AML clinical outcome; explored the role and mechanism of P2X7 in AML progression by using mouse acute myeloid leukemia (AML), nude mouse xenograft and patient-derived xenograft models. High levels of P2X7 expression were correlated with worse survival in AML. P2X7 was highly expressed in MLL-rearranged AML. Furthermore, P2X7 accelerated the progression of MLL-rearranged AML by both promoting cell proliferation and increasing leukemia stem cell (LSC) levels. Moreover, P2X7 caused upregulation of Pbx3 accounts for its pro-leukemic effects. The P2X7-Pbx3 pathway might also contribute to the progression of other types of leukemia as well as solid tumors with high levels of P2X7 expression. Our study provides new insights into the malignant progression caused by abnormal purinergic signaling." @default.
- W3012149196 created "2020-03-23" @default.
- W3012149196 creator A5004483141 @default.
- W3012149196 creator A5007055094 @default.
- W3012149196 creator A5011164870 @default.
- W3012149196 creator A5015412414 @default.
- W3012149196 creator A5020924929 @default.
- W3012149196 creator A5031302163 @default.
- W3012149196 creator A5041914033 @default.
- W3012149196 creator A5042947574 @default.
- W3012149196 creator A5043267366 @default.
- W3012149196 creator A5052076760 @default.
- W3012149196 creator A5067212305 @default.
- W3012149196 date "2020-03-12" @default.
- W3012149196 modified "2023-10-16" @default.
- W3012149196 title "P2X7 promotes the progression of MLL-AF9 induced acute myeloid leukemia by upregulation of Pbx3" @default.
- W3012149196 cites W1605195795 @default.
- W3012149196 cites W1979024008 @default.
- W3012149196 cites W1983757156 @default.
- W3012149196 cites W1988929415 @default.
- W3012149196 cites W1990367576 @default.
- W3012149196 cites W2016467209 @default.
- W3012149196 cites W2020013385 @default.
- W3012149196 cites W2028503582 @default.
- W3012149196 cites W2046540572 @default.
- W3012149196 cites W2050434108 @default.
- W3012149196 cites W2051150230 @default.
- W3012149196 cites W2072023433 @default.
- W3012149196 cites W2079901569 @default.
- W3012149196 cites W2082119653 @default.
- W3012149196 cites W2085850146 @default.
- W3012149196 cites W2119749554 @default.
- W3012149196 cites W2146580269 @default.
- W3012149196 cites W2151149645 @default.
- W3012149196 cites W2205103987 @default.
- W3012149196 cites W2232359723 @default.
- W3012149196 cites W2316466510 @default.
- W3012149196 cites W2408110481 @default.
- W3012149196 cites W2419140434 @default.
- W3012149196 cites W2462051612 @default.
- W3012149196 cites W2509664575 @default.
- W3012149196 cites W2528174093 @default.
- W3012149196 cites W2539202059 @default.
- W3012149196 cites W2580728147 @default.
- W3012149196 cites W2606313052 @default.
- W3012149196 cites W2756901145 @default.
- W3012149196 cites W2768734810 @default.
- W3012149196 cites W2771984155 @default.
- W3012149196 cites W2782637032 @default.
- W3012149196 cites W2787249947 @default.
- W3012149196 cites W2789781727 @default.
- W3012149196 cites W2793668644 @default.
- W3012149196 cites W2793875702 @default.
- W3012149196 cites W2883529501 @default.
- W3012149196 cites W2883768270 @default.
- W3012149196 cites W2883867232 @default.
- W3012149196 cites W2883936808 @default.
- W3012149196 cites W2901801276 @default.
- W3012149196 cites W2911426599 @default.
- W3012149196 cites W2916162780 @default.
- W3012149196 cites W2960793673 @default.
- W3012149196 cites W2965945224 @default.
- W3012149196 cites W2977373639 @default.
- W3012149196 cites W2981340069 @default.
- W3012149196 cites W4210371423 @default.
- W3012149196 cites W71725349 @default.
- W3012149196 doi "https://doi.org/10.3324/haematol.2019.243360" @default.
- W3012149196 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8094107" @default.
- W3012149196 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32165482" @default.
- W3012149196 hasPublicationYear "2020" @default.
- W3012149196 type Work @default.
- W3012149196 sameAs 3012149196 @default.
- W3012149196 citedByCount "23" @default.
- W3012149196 countsByYear W30121491962021 @default.
- W3012149196 countsByYear W30121491962022 @default.
- W3012149196 countsByYear W30121491962023 @default.
- W3012149196 crossrefType "journal-article" @default.
- W3012149196 hasAuthorship W3012149196A5004483141 @default.
- W3012149196 hasAuthorship W3012149196A5007055094 @default.
- W3012149196 hasAuthorship W3012149196A5011164870 @default.
- W3012149196 hasAuthorship W3012149196A5015412414 @default.
- W3012149196 hasAuthorship W3012149196A5020924929 @default.
- W3012149196 hasAuthorship W3012149196A5031302163 @default.
- W3012149196 hasAuthorship W3012149196A5041914033 @default.
- W3012149196 hasAuthorship W3012149196A5042947574 @default.
- W3012149196 hasAuthorship W3012149196A5043267366 @default.
- W3012149196 hasAuthorship W3012149196A5052076760 @default.
- W3012149196 hasAuthorship W3012149196A5067212305 @default.
- W3012149196 hasBestOaLocation W30121491961 @default.
- W3012149196 hasConcept C104317684 @default.
- W3012149196 hasConcept C127561419 @default.
- W3012149196 hasConcept C170493617 @default.
- W3012149196 hasConcept C194409129 @default.
- W3012149196 hasConcept C203014093 @default.
- W3012149196 hasConcept C2778461978 @default.
- W3012149196 hasConcept C2778729363 @default.
- W3012149196 hasConcept C2779282312 @default.
- W3012149196 hasConcept C502942594 @default.